Last reviewed · How we verify
Shade Uvaguard (OXYBENZONE)
At a glance
| Generic name | OXYBENZONE |
|---|---|
| Sponsor | Bayer Healthcare Llc |
| Target | Hormone-sensitive lipase |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1992 |
Approved indications
Common side effects
Key clinical trials
- A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (NA)
- Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products (NA)
- Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products (NA)
- Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products (NA)
- Assessment of the Human Systemic Absorption of Sunscreen Ingredients (PHASE1)
- A Sunscreen Based on Bioadhesive Nanoparticles (PHASE1)
- Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma (PHASE4)
- Multi-Centre European Photopatch Test Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |